C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms

Patents for C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms (18,224)
12/2001
12/05/2001	EP1159237A1 Method of preparing surface-active alcohols and surface-active alcoholic ethers, products obtained by said method and their use
12/05/2001	CN1325431A Electrolumiscent materials
12/05/2001	CN1325395A Method for producing monohalogenated 2-oxo-1,3-dioxolanes using azobisisobutyronitrile
12/05/2001	CN1325394A Method for producing monohulogenated 2-oxo-1,3-dioxolanes
12/04/2001	USH2007 Insecticidal N-heterocyclylalkyl-or N-[(polycyclyl)alkyl]-N′substituted piperazines
12/04/2001	US6326398 Oxamic acids and derivatives as thyroid receptor ligands
12/04/2001	CA2278883C Very large scale immobilized peptide synthesis
12/04/2001	CA2237730C Method and compositions for the synthesis of dioxolane nucleosides with .beta.-configuration
11/2001
11/29/2001	WO2001090099A1 Fatty acid synthase inhibitors
11/29/2001	WO2001090051A1 Phenylglycine derivatives
11/29/2001	US20010047001 Protecting skeletal muscles against trauma damage and subsequent to disease; treating shock and cardiovascular diseases; preserving donor tissue and organs used in transplants
11/29/2001	US20010046960 N-(2,2,2-trifluoroethyl)glycine derivatives; can be used to prepare lipophilic proteins adapted for crossing the blood brain barrier
11/28/2001	EP1157992A1 Dihydro-2,3-Benzodiazepine derivatives
11/28/2001	EP1157001A1 Oxamic acids and derivatives as thyroid receptor ligands
11/28/2001	CN1323794A Novel hetero naphthenic benzcyclobutane and heterocyclo acryl benzcyclobutane compound, their prepn. method and pharmaceutical composites
11/28/2001	CN1075485C Process for prepn. of shikimic acid and its derivatives
11/27/2001	US6323366 Arylamine synthesis
11/27/2001	US6323345 Process for Cis-1-{2-[4-(6-methoxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenoxy]ethyl}pyrrolidine
11/27/2001	US6323227 Prodrugs
11/27/2001	US6323223 Ccr-3 receptor antagonists, pharmaceutical compositions containing them, methods for their use and methods for preparing these compounds.
11/22/2001	WO2001087895A1 Synthetic process for the manufacture of an ecteinaschidin compound
11/22/2001	WO2001087894A1 Antitumoral analogs of et-743
11/22/2001	WO2001087866A1 Cyclohexyl derivatives and their use as therapeutic agents
11/22/2001	WO2001087838A1 Cyclohexane derivatives and their use as therapeutic agents
11/22/2001	WO2001087824A2 7-substituted fused ring tetracycline compounds
11/22/2001	WO2001087822A1 Novel phenyl-propargylether derivatives
11/22/2001	WO2000056681A9 Thiourea and urea liquid-phase combinatorial libraries: synthesis and apoptosis induction
11/22/2001	DE10023484A1 New 2-((cycloalkyl- or heterocyclyl-alkyl)-amino)-benzamide derivatives, are VEGF receptor, KDR kinase and FLT kinase inhibitors useful e.g. for treating tumors, psoriasis, arthritis or renal or ophthalmological diseases
11/22/2001	CA2410077A1 Cyclohexyl derivatives and their use as therapeutic agents
11/22/2001	CA2409063A1 7-substituted fused ring tetracycline compounds
11/22/2001	CA2408849A1 Cyclohexane derivatives and their use as therapeutic agents
11/21/2001	EP1156043A2 Drugs that enhance synaptic responses mediated by ampa receptors
11/21/2001	EP1156042A1 Process for the preparation of glycerol carbonate
11/21/2001	EP1154992A1 N-substituted arylsulfonylamino hydroxamic acids useful as inhibitors of c-proteinase and for treating or preventing disorders related to unregulated collagen production
11/21/2001	EP0952974B1 Biphenyl derivatives substituted by an aromatic or heteroaromatic radical and pharmaceutical and cosmetic compositions containing same
11/21/2001	EP0914319B1 Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists
11/20/2001	US6320085 Process for the preparation of benzyl-ethers
11/20/2001	US6319944 Nmda nr2b antagonists; neurological and neurodegenerative diseases including pain, (and in particular neuropathic pain), epilepsy, stroke, anxiety, cerebral ischemia, muscular spasms, alzheimer's, huntington's and parkinson's diseases
11/15/2001	WO2001085713A1 Use of cyclic ketals as a fragrance
11/15/2001	WO2001085671A2 Anthranyl amides and their use as medicaments
11/15/2001	WO2001085664A2 Compounds and methods for regulating bacterial growth and pathogenesis
11/15/2001	WO2001084929A1 Antitubulin assembly and cell growth inhibitor denominated 'dioxostatin'
11/15/2001	US20010041704 N-(2,6-dimethylphenyl)-2-(4-(2-hydroxy-4-phenylbutyl) -piperazinyl)acetamide, for example; useful to protect skeletal muscles against damage from trauma or disease, treat shock, preserve donor tissue or organs; greater half-life
11/15/2001	DE10022417A1 Novel cyclic ketal compounds are useful as fragrances in cosmetics and cleaning preparations
11/15/2001	CA2408220A1 Antitubulin assembly and cell growth inhibitor denominated "dioxostatin"
11/15/2001	CA2407817A1 Anthranilamides and their use as pharmaceutical agents
11/13/2001	US6316679 Conversion to trimethylolalkane monocyclic formal and trimethylolalkane by transalcoholysis with alcohol in acid catalyst; acetal by-product
11/13/2001	US6316636 Synthesis of fluorocarbon compounds
11/13/2001	US6316625 Methods of making HIV-protease inhibitors and intermediates for making HIV-protease inhibitors
11/13/2001	US6316484 Pentafluorobenzenesulfonamides and analogs
11/13/2001	US6316455 Method of improving the effectiveness of a cytotoxic drug or radiotherapy using a quinazolinone compound
11/13/2001	US6316450 Compounds
11/13/2001	US6316404 Treatment of non-insulin-dependent diabetes mellitus using an rxr agonist alone or in combination with a ppar.gamma. agonist such as a thiazolidinedione compound.
11/13/2001	US6316389 Dihydrobenzene pesticides
11/13/2001	US6316214 ETM-775 metabolite of ecteinascidin 743
11/13/2001	US6316009 Biphenyl derivatives substituted by an aromatic or heteroaromatic radical and pharamaceutical and cosmetic compositions containing same
11/08/2001	WO2001083445A1 Biphenyl butyric acid derivative as a matrix metalloproteinase inhibitor
11/08/2001	WO2000017133A3 Lta4 hydrolase inhibitors
11/08/2001	EP1144348A3 Lta 4? hydrolase inhibitors
11/08/2001	CA2377629A1 Biphenyl butyric acid derivative as a matrix metalloproteinase inhibitor
11/07/2001	EP1150967A1 Therapeutic compounds and methods
11/07/2001	EP1150944A1 N2-phenylamidine derivatives
11/07/2001	EP1066282B1 Novel cationic di-methylenedioxy-benzenes, their use for oxidation dyeing of keratin fibres
11/07/2001	EP0925273B1 Pharmaceutical composition containing 4-oxo-butynic acids
11/07/2001	EP0626939B1 Tri-substituted phenyl derivatives as phosphodiesterase inhibitors
11/07/2001	CN1321144A Method for preparing trion-bis (oxime ether) derivs. and trion-mono and trio-bis (oxime ether) derivs. obtained therewith
11/06/2001	US6313173 Glyoxylic acid amides
11/06/2001	US6313166 Used for pest control, as microbicides, insecticides and acaricides in agriculture, horticulture and in hygiene sector
11/06/2001	US6313146 Calcium receptor-active molecules
11/06/2001	US6313122 As inhibitors of factor xa and are used as anticoagulants in mammals
11/01/2001	WO2001081276A2 Method for producing ketal and/or acetal
11/01/2001	WO2001025225A3 Adducts of glycidylesters of alpha, alpha-branched carboxylic acids and acrylic acids and poly(ortho ester) as intermediate for their preparation
11/01/2001	US20010037039 Non-peptidic; inhibits trypsin-like protease, thrombin and embolus formation; anticoagulant
11/01/2001	US20010036961 For protecting skeletal muscles against damage resulting from trauma or subsequent to muscle or systemic diseases such as intermittent claudication, for treating shock, cardiovascular disorders, for preserving donor tissue, organs in transplants
11/01/2001	US20010036652 Diels-Alder process; antitumor agents
10/2001
10/31/2001	EP1149072A1 Sulfonamide hydroxamates
10/31/2001	EP1149069A1 Phenylglycine derivatives
10/31/2001	EP1149066A1 Method of preparing alkylated salicylamides
10/31/2001	EP1066281B1 Cationic methylenedioxy benzenes, their use for oxidation dyeing of keratin fibres, dyeing compositions and methods
10/31/2001	EP0888292B1 TRICYCLIC COMPOUNDS HAVING ACTIVITY SPECIFIC FOR INTEGRINS, PARTICULARLY ALPHAvBETA3 INTEGRINS, METHOD FOR PREPARING SAME, INTERMEDIATES THEREFOR, USE OF SAID COMPOUNDS AS DRUGS, AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
10/31/2001	EP0717620B1 Substituted 2-aminotetralins
10/31/2001	CN1320117A 2-substituted heterocyclic sulfonamides
10/31/2001	CN1073996C Crystalline form of dihydro-2,3-benzodiazepine derivative
10/31/2001	CN1073995C Physical form of dihydro-2,3-benzodiazepine derivative
10/31/2001	CN1073799C Use of 2-aryl-1-(akoxymethyl)-4-halo-5-(trifluoromethyl) pyrroles.
10/30/2001	US6310246 Fluorovinloxyacetamides, process for preparing same and herbicidal composition comprising same
10/30/2001	US6310189 Nucleotides and analogs having photoremoveable protecting groups
10/30/2001	US6310107 (+)-6-(4-biphenylyl)methoxy-2-(2-(n,n-dimethylamino)ethyl)tetr alin, or a salt is useful for inhibiting production and/or secretion of amyloid-beta protein
10/30/2001	US6310095 Inhibitors of protein isoprenyl transferases
10/30/2001	US6310080 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
10/25/2001	WO2001079157A1 Hydrazide and alkoxyamide angiogenesis inhibitors
10/25/2001	WO2001041778B1 Melanin synthesis inhibition compound and composition containing the same
10/25/2001	CA2406442A1 Hydrazide and alkoxyamide angiogenesis inhibitors
10/24/2001	EP1147101A1 Reverse hydroxamate inhibitors of matrix metalloproteinases
10/24/2001	CN1319007A Medical composition containing nitroetheneamine derivative or salt thereof as active constituent
10/24/2001	CN1318544A Inhibitor used as antioxygen and 5-lipoxygenase, and anti-inflammatory non-steroid carboxylic ester and amide of non-steroid anti-inflammatory agent
10/24/2001	CN1318535A Dihalopropene compound, insecticide/miticide containing the same and intermediate for producing the same
10/23/2001	US6307087 Ligands for metals and improved metal-catalyzed processes based thereon
10/23/2001	US6307069 Easily cleavable under acidic conditions; containing a copolymerizable unsaturated group
10/23/2001	US6307067 Palladium and boron co-catalyzed addition of oxygen nucleophiles to vinyl epoxides

1 ... 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 ... 183